Stay updated on Milademetan Safety in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    There are no substantive changes to the study content; only minor cosmetic and layout adjustments are visible across sections. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:57:47.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Core clinical content (the disease name) was removed; a new version tag (v3.2.0) and an operational status notice were added, signaling a page update and potential deprecation of the previous content.
    Difference
    2%
    Check dated 2025-10-05T08:24:11.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-28T03:00:49.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, indicating a minor update. The 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-13T17:40:04.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T15:22:42.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new medical terms and conditions related to acute myeloid leukemia and myelodysplastic syndrome, while removing several previous terms and drug information.
    Difference
    3%
    Check dated 2025-08-30T11:57:47.000Z thumbnail image

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.